Skip to main content
Erschienen in: Psychiatric Quarterly 2/2020

21.02.2020 | Original Paper

Patterns of Vitamin D Deficiency in a Community Outpatient Psychiatric Practice: a Real-World Evaluation of Treatment Gaps

verfasst von: Oluwole Jegede, Vijay Gayam, Ravindi Gunasekara, Benjamin Tiongson, Adenike Ishola, Jasdeep Sidhu, Jeevanjot Virk, Inderpreet Virk, Saad Ahmed, Olawale Ojo, Chiedozie Ojimba, Christiana Ogunlesi, Tolu Olupona

Erschienen in: Psychiatric Quarterly | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Vitamin D is traditionally recognized for its role in bone mineralization but recent observations suggest additional pertinent functions in neuronal biology. The present study examines the rate and pattern of Vitamin D deficiency in the outpatient mental health clinic of a community teaching hospital as well as the vitamin D supplementation practices of outpatient psychiatrists. Participants include 148 consecutive psychiatric outpatients. Individuals with conditions that alter the metabolism of vitamin D were excluded from the study as are those who may be taking medications that influence Vitamin D metabolism. Statistical analysis was performed using the SPSS 25th edition, statistical significance set at p < 0.05. The majority of patients in the study were between 41 and 65 years old (n = 91, 61.5%), African American (n = 120, 81.1%) and female (n = 80, 54.1%). The median level is 23.7 ng/ml. As defined by the Endocrine Society’s Clinical Practice Guidelines, 68.2% of the population had insufficient and deficient Vitamin D levels (32.4% and 35.8% respectively), 62.4% of whom were not prescribed any Vitamin D supplementation and of this untreated group, 84% were African Americans. No clinical or demographic characteristics showed any statistical difference in both the “treated” and “not treated groups”. Logistic regression did not reveal any significant predictors for Vitamin D deficiency. Vitamin D deficiency remains a significant issue among patients with psychiatric disorders. Our findings show gaps in Vitamin D deficiency treatment and recommend that future studies examine physician prescription practices in light of the racial disparity in Vitamin D deficiency treatment oberved in this study.
Literatur
1.
Zurück zum Zitat Eyles DW, et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009;34(Suppl 1):S247–57.CrossRef Eyles DW, et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009;34(Suppl 1):S247–57.CrossRef
2.
Zurück zum Zitat Zeng Q, Dellenbaugh T, Maldonado M, Moon J, Hornstra R. Vitamin D status of psychiatric inpatients at a community teaching hospital in the Midwest. Nord J Psychiatry. 2016;70(3):208–14.CrossRef Zeng Q, Dellenbaugh T, Maldonado M, Moon J, Hornstra R. Vitamin D status of psychiatric inpatients at a community teaching hospital in the Midwest. Nord J Psychiatry. 2016;70(3):208–14.CrossRef
3.
Zurück zum Zitat Balabanova S, Richter HP, Antoniadis G, Homoki J, Kremmer N, Hanle J, et al. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr. 1984;62(22):1086–90.CrossRef Balabanova S, Richter HP, Antoniadis G, Homoki J, Kremmer N, Hanle J, et al. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr. 1984;62(22):1086–90.CrossRef
4.
Zurück zum Zitat Gascon-Barre M, Huet PM. Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Phys. 1983;244(3):E266–71. Gascon-Barre M, Huet PM. Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Phys. 1983;244(3):E266–71.
5.
Zurück zum Zitat DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev. 2008;66(10 Suppl 2):S73–87.CrossRef DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev. 2008;66(10 Suppl 2):S73–87.CrossRef
6.
Zurück zum Zitat Cebeci AN, Ekici B. Epilepsy treatment by sacrificing vitamin D. Expert Rev Neurother. 2014;14(5):481–91.CrossRef Cebeci AN, Ekici B. Epilepsy treatment by sacrificing vitamin D. Expert Rev Neurother. 2014;14(5):481–91.CrossRef
7.
8.
Zurück zum Zitat Samaniego EA, Sheth RD. Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol. 2007;14(4):196–200.CrossRef Samaniego EA, Sheth RD. Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol. 2007;14(4):196–200.CrossRef
9.
Zurück zum Zitat Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012;523(1):123–33.CrossRef Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012;523(1):123–33.CrossRef
10.
Zurück zum Zitat Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin N Am. 2010;39(2):255–69 table of contents.CrossRef Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin N Am. 2010;39(2):255–69 table of contents.CrossRef
11.
Zurück zum Zitat Prüfer K, Veenstra TD, Jirikowski GF, Kumar R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat. 1999;16(2):135–45.CrossRef Prüfer K, Veenstra TD, Jirikowski GF, Kumar R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat. 1999;16(2):135–45.CrossRef
12.
Zurück zum Zitat Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4–8.CrossRef Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4–8.CrossRef
13.
Zurück zum Zitat Fong CY, Kong AN, Poh BK, Mohamed AR, Khoo TB, Ng RL, et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia. 2016;57(8):1271–9.CrossRef Fong CY, Kong AN, Poh BK, Mohamed AR, Khoo TB, Ng RL, et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia. 2016;57(8):1271–9.CrossRef
14.
Zurück zum Zitat Shellhaas RA, Joshi SM. Vitamin D and bone health among children with epilepsy. Pediatr Neurol. 2010;42(6):385–93.CrossRef Shellhaas RA, Joshi SM. Vitamin D and bone health among children with epilepsy. Pediatr Neurol. 2010;42(6):385–93.CrossRef
15.
Zurück zum Zitat Kim SH, Lee JW, Choi KG, Chung HW, Lee HW. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav. 2007;10(2):291–5.CrossRef Kim SH, Lee JW, Choi KG, Chung HW, Lee HW. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav. 2007;10(2):291–5.CrossRef
16.
Zurück zum Zitat McCue RE, et al. Vitamin d deficiency among psychiatric inpatients. Prim Care Companion CNS Disord. 2012;14(2). McCue RE, et al. Vitamin d deficiency among psychiatric inpatients. Prim Care Companion CNS Disord. 2012;14(2).
17.
Zurück zum Zitat Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of Vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRef Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of Vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRef
18.
Zurück zum Zitat Mulcahy KB, Trigoboff E, Opler L, Demler TL. Physician prescribing practices of vitamin D in a psychiatric hospital. Innov Clin Neurosci. 2016;13(5–6):21–7.PubMedPubMedCentral Mulcahy KB, Trigoboff E, Opler L, Demler TL. Physician prescribing practices of vitamin D in a psychiatric hospital. Innov Clin Neurosci. 2016;13(5–6):21–7.PubMedPubMedCentral
19.
Zurück zum Zitat Rylander M, Verhulst S. Vitamin D insufficiency in psychiatric inpatients. J Psychiatr Pract. 2013;19(4):296–300.CrossRef Rylander M, Verhulst S. Vitamin D insufficiency in psychiatric inpatients. J Psychiatr Pract. 2013;19(4):296–300.CrossRef
20.
Zurück zum Zitat Graham KA, Keefe RS, Lieberman JA, Calikoglu AS, Lansing KM, Perkins DO. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Interv Psychiatry. Graham KA, Keefe RS, Lieberman JA, Calikoglu AS, Lansing KM, Perkins DO. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Interv Psychiatry.
21.
Zurück zum Zitat Toffanello ED, Sergi G, Veronese N, et al. Serum 25-hydroxyvitamin D and the onset of late-life depressive mood in older men and women: the Pro.V.A. study. J Gerontol A Biol Sci Med Sci. 2014;69(12):1554–61.CrossRef Toffanello ED, Sergi G, Veronese N, et al. Serum 25-hydroxyvitamin D and the onset of late-life depressive mood in older men and women: the Pro.V.A. study. J Gerontol A Biol Sci Med Sci. 2014;69(12):1554–61.CrossRef
22.
Zurück zum Zitat Polak MA, Houghton LA, Reeder AI, Harper MJ, Conner TS. Serum 25-hydroxyvitamin D concentrations and depressive symptoms among young adult men and women. Nutrients. 2014;6(11):4720–30.CrossRef Polak MA, Houghton LA, Reeder AI, Harper MJ, Conner TS. Serum 25-hydroxyvitamin D concentrations and depressive symptoms among young adult men and women. Nutrients. 2014;6(11):4720–30.CrossRef
23.
Zurück zum Zitat Spedding S. Vitamin D and depression: a systemic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6:1501–18.CrossRef Spedding S. Vitamin D and depression: a systemic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6:1501–18.CrossRef
24.
Zurück zum Zitat Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2007;10:12–9.CrossRef Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2007;10:12–9.CrossRef
Metadaten
Titel
Patterns of Vitamin D Deficiency in a Community Outpatient Psychiatric Practice: a Real-World Evaluation of Treatment Gaps
verfasst von
Oluwole Jegede
Vijay Gayam
Ravindi Gunasekara
Benjamin Tiongson
Adenike Ishola
Jasdeep Sidhu
Jeevanjot Virk
Inderpreet Virk
Saad Ahmed
Olawale Ojo
Chiedozie Ojimba
Christiana Ogunlesi
Tolu Olupona
Publikationsdatum
21.02.2020
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 2/2020
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-020-09720-x

Weitere Artikel der Ausgabe 2/2020

Psychiatric Quarterly 2/2020 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.